Does DISULFIRAM Cause Malignant neoplasm progression? 7 Reports in FDA Database
Drink Less in 7 Days — Without Willpower
Clinically proven audio program. Just 25 min/day. Already helped 108,000+ people.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with DISULFIRAM (Disulfiram). This represents 0.9% of all adverse event reports for DISULFIRAM.
7
Reports of Malignant neoplasm progression with DISULFIRAM
0.9%
of all DISULFIRAM reports
1
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DISULFIRAM?
Of the 7 reports, 1 (14.3%) resulted in death, 2 (28.6%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DISULFIRAM. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does DISULFIRAM Cause?
Off label use (107)
Fatigue (73)
Drug abuse (68)
Toxicity to various agents (64)
Drug-induced liver injury (46)
Drug interaction (44)
Drug ineffective (43)
Psychiatric symptom (42)
Intentional self-injury (37)
Nausea (33)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DISULFIRAM Alternatives Have Lower Malignant neoplasm progression Risk?
DISULFIRAM vs DIVALPROEX
DISULFIRAM vs DOBUTAMINE
DISULFIRAM vs DOBUTAMINE\DOBUTAMINE
DISULFIRAM vs DOCETAXEL
DISULFIRAM vs DOCETAXEL ANHYDROUS